MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2018 International Congress

    Diagnostic accuracy and imaging correlates of the Free and Cued Selective Reminding Test for screening mild cognitive impairment in Parkinson’s disease

    J. Pagonabarraga, A. Horta-Barba, J. Marín-Lahoz, S. Martinez-Horta, H. Bejr-Kasem, I. Aracil, J. Pérez-Pérez, B. Pascual-Sedano, J. Kulisevsky (Barcelona, Spain)

    Objective: To assess the diagnostic accuracy of FCSRT for screening mild cognitive impairment in PD (PD-MCI), and to correlate FCSRT scores with gray and white…
  • 2018 International Congress

    Distinct networks contribute to the dysexecutive and posterior cortical cognitive syndromes of cognitive impairment in Parkinson’s Disease

    S. Lang, S. Jobert, B. Mejia-Constain, C. Degroot, A. Lafontaine, A. Hanganu, P. Bellec, O. Monchi (Calgary, AB, Canada)

    Objective: The objective of the current study is to relate the network degeneration and the dual syndrome hypothesis of cognitive impairment in Parkinson’s Disease (PD).…
  • 2018 International Congress

    Brain network activation (BNA): A new biomarker for Parkinson’s disease?

    S. Hassin-Baer, Z. Pereman, R. Yahav, S. Israeli-Korn, G. Yahalom, S. Benizri, R. Shani-Hershkovich, G. Issachar, A. Geva, O. Cohen (Ramat Gan, Israel)

    Objective: We aimed to assess the ability of the Brain Network Activation (BNA) EEG analysis algorithm to differentiate between early-stage Parkinson’s disease (PD) patients and…
  • 2018 International Congress

    A study of correlation between screening tools for cognitive decline and gait status using three-dimensional gait analysis

    PJ. Park (Busan, Republic of Korea)

    Objective: The objective of this study is to evaluate the correlation between screening tool for dementia and gait status. Background: Gait impairment in patient with…
  • 2018 International Congress

    Huntington’s Disease in Turkey: A Bird’s Eye Review of the Literature

    Y. Karadag, MA. Akbostanci, H. Hanagasi, N. Subutay Oztekin, M. Demirkiran, AN. Basak (Ankara, Turkey)

    Objective: This study is aimed to make literature review of international/national publications and conference papers on HD from Turkey, aiming to reflect at least partially…
  • 2018 International Congress

    Neuropsychological and clinical assessment for the differential diagnosis of patients with PDD vs. DLB

    E. Fiorenzato, L. Weis, V. Camparini, F. Pistonesi, R. Schifano, E. Gasparoli, A. Antonini, R. Biundo (Venice, Italy)

    Objective: To explore the role of clinical neuropsychological tools in Parkinson’s disease-dementia (PDD) vs. dementia with Lewy bodies (DLB). First, to define the feasibility of…
  • 2018 International Congress

    Selection of antiparkinson drug and cognition in Japanese Parkinson Disease patients

    K. Konaka, Y. Kajiyama, R. Gajanan, M. Mihara, N. Hattori, H. Mochizuki (Suita, Japan)

    Objective: We attempted to analyze the correlation between dementia and internal medicine furthermore by elucidating the relevance to the frequently administered combination of antiparkinson drug.…
  • 2018 International Congress

    Meta-Analysis of Short-afferent inhibition and Cognitive Impairment in Parkinson’s Disease

    J.F. Martin-Rodriguez, P. Mir (Seville, Spain)

    Objective: In this meta-analysis, we assess whether short-afferent inhibition (SAI) is impaired in Parkinson's disease (PD) patients as well as identify clinical variables associated to…
  • 2018 International Congress

    Balance and gait analysis of GBA mutation carriers with Parkinson’s disease (PD)

    A. Gera, J. Okeefe, N. Purcell, C. Huml, S. Ruehl, B. Ouyang, G. Pal (Chicago, IL, USA)

    Objective: To use quantitative inertial sensor-based postural sway and gait analysis to determine potential differences in the pattern of balance and gait impairment in the…
  • 2018 International Congress

    Amyloid PET and cognition in Parkinson’s disease

    T. Melzer, M. Stark, D. Myall, R. Keenan, L. Livingston, M. Almuqbel, M. MacAskill, T. Pitcher, K. Horne, S. Grenfell, M. Pascoe, B. Young, J. Wang, S. Marsh, D. Miller, J. Dalrymple-Alford, T. Anderson (Christchurch, New Zealand)

    Objective: To investigate the relationship between cerebral amyloid accumulation and cognition in Parkinson’s disease (PD). Background: The neuropathology underlying the development of dementia in Parkinson’s…
  • « Previous Page
  • 1
  • …
  • 106
  • 107
  • 108
  • 109
  • 110
  • …
  • 141
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley